Jorg Trojan MD

Dr. Jorg Trojan is a Professor of Medicine and Head of the Gastrointestinal Oncology Unit within the Department of Medicine 1, Goethe University Hospital and University Cancer Center Frankfurt, one of the largest comprehensive cancer centers in Germany. He was appointed in 2008 to his current position. His clinical areas of expertise include gastrointestinal oncology, gastroenterology & hepatology, and gastrointestinal endoscopy. After receiving his medical training from the Goethe University Medical School (Frankfurt, Germany), Ruprecht-Karls-University (Heidelberg, Germany), Duke Medical School (Durham, NC, USA), and Baylor College (Houston, Tx, USA) Dr. Trojan completed post-doctoral fellowships in gastroenterology at the University Hospital in Frankfurt and carried out research at the Institute of Molecular Cancer Research, the University of Zurich on DNA mismatch repair deficiency. Dr. Trojan’s current research interests include immuno-oncological treatments and biomarkers in gastrointestinal cancer with a special focus on hepatocellular carcinoma, cholangiocarcinoma, and pancreatic and colorectal cancer. Currently, he is conducting several pivotal studies in these entities as the national lead investigator. He has co-authored and authored numerous manuscripts, book chapters, and reviews, including publications in Lancet, Lancet Oncology, Annals of Oncology, Gastroenterology, Hepatology, and Journal of Hepatology. He is a member of the German Cancer Society and the German Society for Digestive and Metabolic Diseases (DGVS). He is a steering committee member of the national S3 guidelines on hepatocellular cancer and biliary tract cancer and additionally has co-authored the national S3 guidelines on esophageal cancer and colorectal cancer. Prof. Trojan is an advisor of the independent Institute for Quality and Efficiency in Health Care (IQWiG).